NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 61.6% | 22.3% | -57.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.8% | 53.9% | 55.6% | 58.9% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -56.7% | -84% | -159% | 66.4% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -59.1% | -88.5% | -163.8% | 54.5% |
| EPS Diluted | -0.044 | -0.031 | -0.073 | 0.058 |
| % Growth | -42.1% | 57.7% | -226.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |